These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1013381)

  • 21. [Changes in the lipid content of erythrocytes in patients with chronic renal failure].
    Witkowska J; Bober J; Chlubek D
    Ann Acad Med Stetin; 2007; 53(2):46-51. PubMed ID: 18557376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the lipid metabolism of the nephrotic syndrome (author's transl)].
    Senaga R
    Rinsho Byori; 1975 Oct; 23(10):782-6. PubMed ID: 1240491
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythrocyte peroxide metabolism, plasma lipid pattern and hemorheological profile in chronic renal failure.
    Caimi G
    J Nephrol; 2002; 15(2):104-8. PubMed ID: 12018624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kidney diseases and serm proteins].
    Hirano Y; Nagai M; Iuchi I; Sasaki M
    Rinsho Byori; 1970 Nov; 18(11):779-87. PubMed ID: 5533730
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipids of human red cell membrane: normal composition and variability in disease.
    Cooper RA
    Semin Hematol; 1970 Jul; 7(3):296-322. PubMed ID: 4915341
    [No Abstract]   [Full Text] [Related]  

  • 27. Serumlipoproteins in children with nephrotic syndrome and chronic renal failure.
    Widhalm K; Singer P; Balzar E
    Artery; 1980; 8(2):191-8. PubMed ID: 7458686
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum vitamin E and fatty acid composition of the red cell membrane phospholipids in patients with chronic renal failure treated by hemodialysis.
    Heldenberg D; Blum M; Levtow O; Maisner I
    Clin Nephrol; 1982 Nov; 18(5):272. PubMed ID: 7151344
    [No Abstract]   [Full Text] [Related]  

  • 29. Red cell lipids in liver disease: relationship to serum lipids and to lecithin-cholesterol acyltransferase.
    Simon JB
    J Lab Clin Med; 1971 Jun; 77(6):891-900. PubMed ID: 5559858
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in serum and erythrocyte lipid in liver diseases].
    Hashihira S; Yamadori T; Takeda Y; Mori T; Mihara M
    Rinsho Byori; 1971 Aug; 19():Suppl:300. PubMed ID: 5167990
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of the fatty acids of the blood during nephrotic syndromes].
    Warembourg H; Biserte G; Bertrand M; Jaillard J; Sézille G
    J Urol Nephrol (Paris); 1967; 73(4):286-95. PubMed ID: 6057516
    [No Abstract]   [Full Text] [Related]  

  • 32. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure].
    Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa
    Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell lipids in patients with end-stage renal failure: relationship to osmotic fragility.
    Sasaki S
    Osaka City Med J; 1977; 23(1):85-98. PubMed ID: 609453
    [No Abstract]   [Full Text] [Related]  

  • 34. [Coagulation and fibrinolysis alterations in renal failure (author's transl)].
    Rocha E; Sánchez Ibarrola A; Arrizabalaga B; Páramo JA; Purroy A
    Sangre (Barc); 1980; 25(5B):740-59. PubMed ID: 7008223
    [No Abstract]   [Full Text] [Related]  

  • 35. [The serum magnesium level in kidney diseases].
    Klete H
    Z Gesamte Inn Med; 1967 Dec; 22(23):756-62. PubMed ID: 5590637
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G; Kouame C
    Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperlipoproteinemia in the nephrotic syndrome].
    Yasugi T; Shimizu T; Iijima M; Tomita M; Harada M
    Saishin Igaku; 1972 Mar; 27(3):504-9. PubMed ID: 5021394
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of hematological findings in the diagnosis of renal diseases with special reference to abnormal morphology of the erythrocytes].
    Hashimoto K; Oba Y; Oyama H; Wajima T
    Rinsho Byori; 1970 Nov; 18(11):774-8. PubMed ID: 5533729
    [No Abstract]   [Full Text] [Related]  

  • 39. [The study of impaired reducing power in chronic renal failure patients with emphasis on red blood cells and lipoperoxide (author's transl)].
    Kawaguchi S; Maeda K; Tsutsui S; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):401-12. PubMed ID: 7401393
    [No Abstract]   [Full Text] [Related]  

  • 40. [Basal gastrin content of the blood in kidney diseases].
    Ryss ES; Riabov SI; Lutoshkin MB
    Klin Med (Mosk); 1985 Jan; 63(1):95-9. PubMed ID: 3990196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.